Prolonged survival of skin allografts in rats treated with heterologous anti-skin serum

PMID: 4190337Jan 1, 1970Paper

Prolonged survival of skin allografts in rats treated with heterologous anti-skin serum

Clinical and Experimental Immunology

M Cohen, D Nelken

Get PDF

Abstract

No abstract listed.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Prolonged survival of skin allografts in rats treated with heterologous anti-skin serum

Abstract

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Related Papers

Effects of "surrounding needling" on hydroxyproline content and ultrastructures in the dermis of aged rats

Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses

Immune response to gamma-irradiated injectable human amnion and human skin collagens in the rat

Chemoprevention of skin cancer with 1,1-Bis (3'-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1)

5-epi-Sinuleptolide induces cell cycle arrest and apoptosis through tumor necrosis factor/mitochondria-mediated caspase signaling pathway in human skin cancer cells